Tag: Eversense CGM

PARSIPPANY, N.J. – Ascensia Diabetes Care, maker of the Contour Blood Glucose Monitoring (BGM) System portfolio and exclusive distributor of Eversense Continuous Glucose Monitoring (CGM) Systems, announces that it has significantly expanded Eversense PASS, a payment assistance and simple savings program designed to enhance affordability and access to the Eversense E3. Under the new and improved program, there will be more people with diabetes eligible for assistance paying for the system and...

PARSIPPANY, N.J. – Ascensia Diabetes Care has launched the next-generation Eversense E3 Continuous Glucose Monitoring System for patients in the U.S., alongside the new Eversense PASS savings program. Eversense E3, which is developed be Senseonics Holdings, was approved for use up to six months by the U.S. Food and Drug Administration earlier this year, making it the longest lasting CGM sensor available in the country. “We are thrilled to offer Eversense E3 to people with diabetes in...